Subscribe to MDT Magazine News

Class I Medical Device Recall: B. Braun, Outlook 400ES Safety Infusion System, Model Number 621-400ES

January 31, 2011 11:31 am | by U.S. Food & Drug Administration | Comments

The B. Braun Outlook 400ES Safety Infusion System is intended for use with B. Braun Medical Inc. Horizon Pump IV Sets to regulate the flow of primary and secondary fluids when positive pressure is required. The infusion system is capable of delivering...

Haemonetics fiscal 3Q net income rises 8 percent

January 31, 2011 10:45 am | by The Associated Press | Comments

Blood collection and processing systems maker Haemonetics Corp. said Monday its fiscal third-quarter net income climbed about 8 percent, helped in part by a recovering plasma products business.The Braintree, Mass., company earned $19.7 million, or 77 cents per share, in the three months that...

Springer to publish Cellular Oncology

January 31, 2011 10:39 am | by EurekAlert | Comments

(Springer) Springer and the International Society of Cellular Oncology (ISCO) will collaborate to publish Cellular Oncology starting this year. Cellular Oncology is the official journal of ISCO and publishes original papers and reviews on the latest advances in cancer research. It...


KACST-INTEL CENA kicks off research at imec

January 31, 2011 10:39 am | by I-Micronews | Comments

King Abdulaziz City of Science and Technology (KACST) signed agreement today with imec, a world-leading nanoelectronics research center headquartered in Belgium, to host researchers from KACST-INTEL consortium Center of Excellence in Nano-manufacturing Applications (CENA) at imec...

Master bond UV curable adhesives, sealants, coatings, and potting & encapsulation compounds

January 31, 2011 10:39 am | by I-Micronews | Comments

Master Bond UV curable bonding, sealing, coating, and potting & encapsulation compounds are one component systems that require no weighing or mixing prior to use. They are designed to speed productivity, eliminate waste, save energy, increase efficiency, and improve reliability.

Boston Scientific's Renegade device gets FDA nod(2)

January 31, 2011 10:38 am | by Mass High Tech: The Journal of New England Technology | Comments

The U.S. Food and Drug Administration has approved Boston Scientific Corp.'s Renegade HI-FLO Fathom Pre-Loaded System, developed to treat uterine fibroids and liver cancer.

PCMA: Ohio's Medicaid Program Could Save $135 Million

January 31, 2011 10:37 am | by Bio-Medicine.Org | Comments

WASHINGTON, Jan. 31, 2011 /PRNewswire-USNewswire/ -- Ohio's Medicaid program could cost taxpayers an additional $1.6 billion next year, a 49 percent jump in the state's share of costs for the health care program covering more than 2 million poor and disabled Ohioans, according to new...


New Interim Leadership for USP-Brazil

January 31, 2011 10:36 am | by Bio-Medicine.Org | Comments

ROCKVILLE, Md., Jan. 31, 2011 /PRNewswire-USNewswire/ -- To further its continuing partnerships with Brazilian public health authorities and pharmaceutical manufacturers, the U.S. Pharmacopeial Convention (USP) has appointed Mr. Nelson dos Santos as interim vice president of its Sao...


Southampton scientists begin patient trials of new leukemia cancer vaccine

January 31, 2011 8:39 am | by EurekAlert | Comments

(University of Southampton) A new cancer treatment which strengthens a patient's immune system and enables them to fight the disease more effectively is being trialled on patients for the first time in the UK.


Boston Scientific's Renegade device gets FDA nod

January 31, 2011 8:34 am | Comments

The U.S. Food and Drug Administration has approved Boston Scientific Corp.'s Renegade HI-FLO Fathom Pre-Loaded System, developed to treat uterine fibroids and liver cancer.

DNA Direct Announces New Health Plan Clients Managing Molecular Diagnostic and Genetic Tests

January 31, 2011 7:33 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, Jan. 31, 2011 /- DNA Direct, a wholly owned subsidiary of Medco Health Solutions, Inc. (NYSE: MHS ) and a provider of guidance and decision support for genomic medicine, today announced four new health plan clients that are implementing DNA Direct's Policy & Benefit...


ImaginAb, Inc. and Eurogentec S.A. Collaborate to Produce Antibody Fragments in Pichia

January 31, 2011 7:32 am | by Bio-Medicine.Org | Comments

LOS ANGELES, Jan. 31, 2011 /- ImaginAb, Inc. and Eurogentec S.A. announce a development collaboration to establish a novel system for producing engineered antibody fragments. The two companies will produce ImaginAb's optimized antibody fragments with Eurogentec's high-performance Pichia...


Covidien, Massimo extend royalty deal for 3 years

January 31, 2011 5:45 am | by The Associated Press | Comments

Medical device and drug maker Covidien PLC said Monday it extended a royalty agreement with medical technology company Masimo Corp. for its pulse oximetry products — devices that monitor oxygen in the bloodstream — sold in the United States.Covidien, which is based in Ireland, will pay Masimo, of...

PDI to Present at the UBS 21st Annual Global Healthcare Services Conference

January 31, 2011 5:36 am | by Bio-Medicine.Org | Comments

PARSIPPANY, N.J., Jan. 31, 2011 /- PDI, Inc. (Nasdaq: PDII ) today announced that Nancy Lurker, the company's chief executive officer, is scheduled to present at the UBS 21st Annual Global Healthcare Services Conference at 3:30 pm ET on February 8, 2011 at the Grand Hyatt New York. The...


Qforma, Leading Provider of Healthcare Analytics, Announces Three New Appointments

January 31, 2011 5:35 am | by Bio-Medicine.Org | Comments

SANTA FE, N.M. and PRINCETON, N.J., Jan. 31, 2011 /- Qforma, the leading provider of advanced analytics and predictive modeling technologies for the health sciences industry, today announced the appointments of Ted Pine and Devon Reimer as Vice Presidents of Business Development, and...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.